Traduction de «for the secondary cardiovascular prevention » (Français → Néerlandais) :

Concept paper on the development of a CHMP note for guidance on the need for regulatory guidance in the evaluation of medicinal products for the secondary cardiovascular prevention
Concept paper on the development of a CPMP points to consider on clinical investigation of medicinal products for the treatment of chronic hepatitis B

Deux très grands essais cliniques, qui apporteront certainement plus de clarté à ce sujet sont encore en cours: ACCEPT-D (‘Aspirin and Simvastatin combination for Cardiovascular Events Prevention Trial in Diabetes’) et ASCEND (‘A Study of Cardiovascular Events in Diabetes’).
Twee zeer grote trials, die wellicht meer klaarheid over dit onderwerp zullen kunnen brengen zijn nog lopende: ACCEPT-D (Aspirin and Simvastatin combination for Cardiovascular Events Prevention Trial in Diabetes) en ASCEND (A Study of Cardiovascular Events in Diabetes).

46. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease.
cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

Analyse de: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
Bespreking van: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

Afilalo J, Duque G, Steele R et al. Statins for secondary prevention in elderly patients.
Ray KK, Seshasai SRK, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention.

1 Lip GY, Kalra L. Stroke: secondary prevention.
1 Alhusban A, Fagan SC. Secondary prevention of stroke in elderly: a review of the evidence.

4 Scottish Intercollegiate Guidelines Network. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention.
investigation, immediate management and secondary prevention.

49. NICE. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.
hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.

Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
DOI: 10.1002/14651858.CD000254.pub3. Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.